Cleveland BioLabs

$5.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.84%) Today

$0.00 (0.00%) As of 9:13 PM UTC after-hours

Why Robinhood?

You can buy or sell CBLI and other stocks, options, and ETFs commission-free!

About CBLI

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. The listed name for CBLI is Cleveland BioLabs, Inc. Common Stock.

CEO

Christopher Zosh

Employees

Headquarters

Buffalo, New York

Founded

2003

Market Cap

86.67M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.10M

High Today

$5.93

Low Today

$5.54

Open Price

$5.86

Volume

277.49K

52 Week High

$10.97

52 Week Low

$1.27

CBLI Earnings

-$0.80

-$0.53

-$0.27

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Apr 14, After Hours